Cargando…
Liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison
BACKGROUND: To compare patient survival after liver transplantation (LT) for hepatocellular carcinoma (HCC) from live donors (LD) or extended criteria donors (ECD). METHODS: Data from consecutive LT procedures for HCC involving either LD or ECD were reviewed. Patient survival was our primary outcome...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191876/ https://www.ncbi.nlm.nih.gov/pubmed/30386123 http://dx.doi.org/10.20524/aog.2018.0301 |
_version_ | 1783363798199959552 |
---|---|
author | Sotiropoulos, Georgios C. Spartalis, Eleftherios Machairas, Nikolaos Paul, Andreas Malagó, Massimo Neuhäuser, Markus |
author_facet | Sotiropoulos, Georgios C. Spartalis, Eleftherios Machairas, Nikolaos Paul, Andreas Malagó, Massimo Neuhäuser, Markus |
author_sort | Sotiropoulos, Georgios C. |
collection | PubMed |
description | BACKGROUND: To compare patient survival after liver transplantation (LT) for hepatocellular carcinoma (HCC) from live donors (LD) or extended criteria donors (ECD). METHODS: Data from consecutive LT procedures for HCC involving either LD or ECD were reviewed. Patient survival was our primary outcome. Re-transplantation (Re-LT), ischemic type bile lesions (ITBL), and tumor recurrence represented secondary outcomes. The primary outcome was statistically analyzed using Kaplan-Meier estimates and Cox proportional hazards regression; logistic regression analyses were used for statistical analysis of the secondary outcomes. Propensity score was calculated based on patient age, sex, hepatitis C viral infection (HCV), laboratory model for end-stage liver disease (labMELD) score, bridging treatment, Milan criteria, α-fetoprotein levels, and tumor grade. RESULTS: The study evaluated 109 recipients undergoing LT from either LD (n=57) or ECD (n=52). LT procedure (hazard ratio [HR] 2.349, 95% confidence interval [CI] 1.151-4.794, P=0.0190), age (HR 1.075, 95%CI 1.020-1.133, P=0.0074) and labMELD score (HR 1.082, 95%CI 1.021-1.147, P=0.0075) reached significance by Cox proportional hazards regression. After adjustment with the propensity score (stratification with 5 strata), the LT procedure was still significant (HR 2.401, 95%CI 1.114-5.175, P=0.0253). Tumor grade (odds ratio [OR] 9.628, 95%CI 1.120-82.752, P=0.0391), labMELD score (OR 1.224, 95%CI 1.019-1.471, P=0.0306), and Milan criteria (OR 6.375, 95%CI 1.239-32.796, P=0.0267) gained statistical significance by logistic regression analysis for Re-LT, ITBL, and tumor recurrence, respectively. CONCLUSIONS: LT for HCC showed superior patient survival with ECD rather than LD grafts. Re-LT, ITBL, and tumor recurrence showed no significant differences between the two groups. However, the diverging criteria for the definition of ECD grafts represent a considerable limitation for the wide application of this policy. |
format | Online Article Text |
id | pubmed-6191876 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Hellenic Society of Gastroenterology |
record_format | MEDLINE/PubMed |
spelling | pubmed-61918762018-11-01 Liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison Sotiropoulos, Georgios C. Spartalis, Eleftherios Machairas, Nikolaos Paul, Andreas Malagó, Massimo Neuhäuser, Markus Ann Gastroenterol Original Article BACKGROUND: To compare patient survival after liver transplantation (LT) for hepatocellular carcinoma (HCC) from live donors (LD) or extended criteria donors (ECD). METHODS: Data from consecutive LT procedures for HCC involving either LD or ECD were reviewed. Patient survival was our primary outcome. Re-transplantation (Re-LT), ischemic type bile lesions (ITBL), and tumor recurrence represented secondary outcomes. The primary outcome was statistically analyzed using Kaplan-Meier estimates and Cox proportional hazards regression; logistic regression analyses were used for statistical analysis of the secondary outcomes. Propensity score was calculated based on patient age, sex, hepatitis C viral infection (HCV), laboratory model for end-stage liver disease (labMELD) score, bridging treatment, Milan criteria, α-fetoprotein levels, and tumor grade. RESULTS: The study evaluated 109 recipients undergoing LT from either LD (n=57) or ECD (n=52). LT procedure (hazard ratio [HR] 2.349, 95% confidence interval [CI] 1.151-4.794, P=0.0190), age (HR 1.075, 95%CI 1.020-1.133, P=0.0074) and labMELD score (HR 1.082, 95%CI 1.021-1.147, P=0.0075) reached significance by Cox proportional hazards regression. After adjustment with the propensity score (stratification with 5 strata), the LT procedure was still significant (HR 2.401, 95%CI 1.114-5.175, P=0.0253). Tumor grade (odds ratio [OR] 9.628, 95%CI 1.120-82.752, P=0.0391), labMELD score (OR 1.224, 95%CI 1.019-1.471, P=0.0306), and Milan criteria (OR 6.375, 95%CI 1.239-32.796, P=0.0267) gained statistical significance by logistic regression analysis for Re-LT, ITBL, and tumor recurrence, respectively. CONCLUSIONS: LT for HCC showed superior patient survival with ECD rather than LD grafts. Re-LT, ITBL, and tumor recurrence showed no significant differences between the two groups. However, the diverging criteria for the definition of ECD grafts represent a considerable limitation for the wide application of this policy. Hellenic Society of Gastroenterology 2018 2018-07-27 /pmc/articles/PMC6191876/ /pubmed/30386123 http://dx.doi.org/10.20524/aog.2018.0301 Text en Copyright: © Hellenic Society of Gastroenterology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Sotiropoulos, Georgios C. Spartalis, Eleftherios Machairas, Nikolaos Paul, Andreas Malagó, Massimo Neuhäuser, Markus Liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison |
title | Liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison |
title_full | Liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison |
title_fullStr | Liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison |
title_full_unstemmed | Liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison |
title_short | Liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison |
title_sort | liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191876/ https://www.ncbi.nlm.nih.gov/pubmed/30386123 http://dx.doi.org/10.20524/aog.2018.0301 |
work_keys_str_mv | AT sotiropoulosgeorgiosc livertransplantationforhepatocellularcarcinomawithlivedonorsorextendedcriteriadonorsapropensityscorematchedcomparison AT spartaliseleftherios livertransplantationforhepatocellularcarcinomawithlivedonorsorextendedcriteriadonorsapropensityscorematchedcomparison AT machairasnikolaos livertransplantationforhepatocellularcarcinomawithlivedonorsorextendedcriteriadonorsapropensityscorematchedcomparison AT paulandreas livertransplantationforhepatocellularcarcinomawithlivedonorsorextendedcriteriadonorsapropensityscorematchedcomparison AT malagomassimo livertransplantationforhepatocellularcarcinomawithlivedonorsorextendedcriteriadonorsapropensityscorematchedcomparison AT neuhausermarkus livertransplantationforhepatocellularcarcinomawithlivedonorsorextendedcriteriadonorsapropensityscorematchedcomparison |